BlueStar
Baltimore, Maryland-based WellDoc has raised $22 million in a round led by Samsung Ventures and Merck Global Health Innovation (GHI) Fund with participation from Adage Capital Management, Excel Venture Management, Alexandria Venture Investments and Hudson River Capital Partners.
WellDoc and Samsung will bring a new version of WellDoc's BlueStar mobile prescription therapy for diabetes to 300 Toronto citizens in partnership with the Ontario Telemedicine Network (OTN), a Canadian government-funded nonprofit.
A recent column in the Harvard Business Review says that two kinds of business strategies will dominate in the gold rush-like healthcare economy of the future: Goldminers and Bartenders.
During a fireside chat at the annual Khosla Ventures CEO summit, investor Vinod Khosla talked to Google co-founders Larry Page and Sergey Brin about Google becoming a health company one day.